A new implant for keratoconus to avoid corneal transplant
Part of Eyes & vision clinical trials.
This trial tests a small metal implant placed in the cornea to treat keratoconus, a condition where the cornea thins and bulges. The goal is to see if the implant can safely improve vision and prevent the need for a corneal transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your cornea must be at least 350 micrometers thick at its thinnest point.
- Your vision with glasses must be poor (0.30 logMAR or worse), but improving significantly with special contact lenses.
- Your keratoconus must be considered advanced (stage 3–4) and stable for at least 12 months.
- You must not have an allergy to nickel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether prescription inserts placed in the cornea can improve day-to-day vision for people with keratoconus whose vision is getting worse and who have few options left. You may be able to avoid or delay corneal transplant depending on your cornea shape and thickness.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This trial studies placing small rings inside the clear front surface of the eye to improve vision in people whose corneas have progressively weakened. It may help if glasses or contacts no longer give you enough day-to-day vision and a transplant is otherwise the only option.
This study tests a lab-grown (ex vivo) method of strengthening donor cornea tissue used in cornea transplants for people with keratoconus. It may help improve how well the transplanted cornea heals and functions.
This trial tests a new eyedrop (TN-001) for people with keratoconus that is getting worse. The drops are applied twice a day to try to stop the cornea from thinning and bulging further.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.